Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.
Am J Hematol
; 99(7): 1437-1440, 2024 07.
Article
in En
| MEDLINE
| ID: mdl-38712616
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dendritic Cells
/
Immunotherapy, Adoptive
/
Antigens, CD19
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2024
Document type:
Article
Affiliation country: